Compassionate use of psychedelics
Greif, A., & Šurkala, M. | Medicine, Health Care, and Philosophy | 23 September 2020
P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap
Smigielski, L., Kometer, M., Scheidegger, M., Stress, C., Preller, K. H., Koenig, T., & Vollenweider, F. X. | Human brain mapping | 21 Aug 2020
Psychedelic science in post-COVID-19 psychiatry
Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., & O’Keane, V. | Irish journal of psychological medicine | 19 Aug 2020
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Breeksema, J. J., Niemeijer, A. R., Krediet, E., Vermetten, E., & Schoevers, R. A | CNS drugs | 17 August 2020
Ibogaine therapy for addiction: Consumer views from online fora
Barber, M., Gardner, J., Savic, M., & Carter, A. | Journal of Drug Policy | 18 July 2020
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N., Palhano-Fontes, F., Campos Braga, I., Lobão Soares, B., de Araujo, D. B. | Journal of Psychopharmacology | 10 Jul 2020
Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans
Davis, A. K., Averill, L. A., Sepeda, N. D., Barsuglia, J. P., & Amoroso, T. | Chronic Stress | 8 July 2020
Historic psychedelic drug trials and the treatment of anxiety disorders
Weston, N. M., Gibbs, D., Bird, C. I., Daniel, A., Jelen, L. A., Knight, G., & Rucker, J. J. | Depression and Anxiety | 05 July 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
Jardim, A. V., Jardim, D. V., Chaves, B. R., Steglich, M., Ot’alora G, M., Mithoefer, M. C., Doblin, R. | Brazilian Journal of Psychiatry | 3 July 2020
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
Varley, T. F., Carhart-Harris, R., Roseman, L., Menon, D. K., & Stamatakis, E. A. | NeuroImage | 30 June 2020
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., & Lim, K. O. | Translational psychiatry | 26 June 2020
Psilocybin occasioned mystical-type experiences
James, E., Robertshaw, T. L., Hoskins, M., & Sessa, B. | Human Psychopharmacology: Clinical and Experimental | 23 June 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. | Expert Review of Clinical Pharmacology | 1 June 2020
Spotlight commentary: REBUS and the anarchic brain
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 12 June 2020
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. | Journal Of Psychoactive Drugs | 12 June 2020
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Kangaslampi, S., Hausen, A., & Rauteenmaa, T. | Journal of Psychoactive Drugs | 8 June 2020
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism
van Mulukom, V., Patterson, R., & van Elk, M. | Psychopharmacology (Berl) | 29 May 2020
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., ... & Ramaekers, J. G. | Neuropsychopharmacology | 23 May 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)
Fu, D. J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., ... & Canuso, C. M. | 12 May 2020 | The Journal of clinical psychiatry
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
Morgan, L. | Annals of General Psychiatry | 12 May 2020
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. | The Journal of Antibiotics | 12 May 2020
Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials
Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., ... & Doblin, R. | Psychopharmacology | 11 May 2020
Psychedelic treatment of functional neurological disorder: a systematic review
Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A., Lees, A., ... & Rucker, J. | Therapeutic Advances in Psychopharmacology | 11 May 2020
Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose
Johnson, S., & Black, Q. C. | Journal of Psychoactive Drugs | 7 May 2020